Cv english.doc

Al-Azhar University
Tel: Office 02 22633993
Faculty of Pharmacy
Home 02 26390321
Dept. of Pharmaceutics and Industrial Pharmacy
mobile 0106735004
Nasr City, Cairo, Egypt
02 22625796
CURRICULUM VITAE

Personal information

Present Profession

Professor of pharmaceutics. Head of pharmaceutics and industrial pharmacy Dept., Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.
Qualifications

1- B.Sc. Pharm., Faculty of Pharmacy, Cairo University, May 1974.

2- M.Sc. Pharmaceutics, Faculty of Pharmacy, Cairo University, October 1980,
"Studies on Certain Pharmaceutical Topical Preparations of Iodo chloro hydroxy
quinoline"

3- Ph.D. Pharmaceutics, UWIST (University of Wales, Institute of Sciences and
Technology), United Kingdom, June 1986, " Micellization of Phenothiazines and

Present Job
Head of Pharmaceutics and industrial pharmacy Dept., Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt. PDF created with pdfFactory Pro trial versi Academic career
1- Demonstrator in the Pharmaceutics and Industrial Pharmacy Dept., Faculty of
Pharmacy, Cairo University from 29/10/1974 to 30/12/1980.

2- Assistant lecturer in the Pharmaceutics and Industrial Pharmacy Dept., Faculty
of Pharmacy, Cairo University from 31/12/1980 to 30/6/1982.

3- Transferred as a governmental mission on behalf of Faculty of Pharmacy, Al-
Azhar University from 1/7/1982.

4- I got a governmental mission leading to Ph. D. degree from School of
Pharmacy in Wal s, University of Walls, Institute of Sciences and Technology
(UWIST), United Kingdom from 2/7/1982 to 30/6/1986.

5- Lecturer in the Pharmaceutics and Industrial Pharmacy Dept., Faculty of
Pharmacy, Al-Azhar University from 30/8/1986 to 8/10/1993.

6- Assistant Professor in the Pharmaceutics and Industrial Pharmacy Dept.,
Faculty of Pharmacy, Al-Azhar University from 9/10/1993 to 3/11/1998.

7- Professor in the Pharmaceutics and Industrial Pharmacy Dept., Faculty of
Pharmacy, Al-Azhar University from 4/11/1998 until now.

8- Head of Pharmaceutics and Industrial Pharmacy Dept., Faculty of Pharmacy,
Al-Azhar University from 20/3/2002 until now.

PDF created with pdfFactory Pro trial versi Scientific and career activities
1- Active member in the Egyptian Pharmaceutical Syndicate from 1974.

2- Member of the Egyptian Pharmaceutical Association from 1974.

3- Member in the Academic staff club, Cairo University from 1974 to 1982.

4- Member in the Academic staff club, Al-Azhar University from 1982.

5- Honor of the Pharmaceutics and Industrial Pharmacy department Council from
1/10/1986 to 2/5/1989.

6- Head of the Esraa family in Faculty of Pharmacy, Al-Azhar University 1993 and
1994.

7- Head of the First year control in Faculty of Pharmacy, Al-Azhar University,
academic year 1993/1994.

8- Honor of the Pharmaceutics and Industrial Pharmacy department Council from
20/11/1995 to 19/3/2002

9- Head of the Second year control in Faculty of Pharmacy, Al-Azhar University,
academic years 1994/1995 and 1995/1996.

10- Active member in the Egyptian Association of Bio-Technology from 1996.

11- Manager of the central laboratory in Faculty of Pharmacy, Al-Azhar University

12- Active member in the Egyptian Association of Clinical Chemistry from 1997.

13- Active member in the Educational Services Association in Faculty of
Pharmacy, Al-Azhar University from 1997.

14- Head of the First year control in Faculty of Pharmacy, Al-Azhar University,

15- Head of the Second year control in Faculty of Pharmacy, Al-Azhar University,
academic year 1999/2000.

16- Head of the general controls management in Faculty of Pharmacy, Al-Azhar
University, August 2000 and November 2000.

17- Head of the general controls management in Faculty of Pharmacy, Al-Azhar
University, academic year 2000/2001.

18- Head of the general controls management in Faculty of Pharmacy, Al-Azhar
University, academic year 2001/2002.
PDF created with pdfFactory Pro trial versi 19- Honor of the Faculty of Pharmacy Council from 1/9/2001 to 21/5/2002.

20- Head of the Third year control in Faculty of Pharmacy, Al-Azhar University,
academic year 2001/2002.

21- Head of the Pharmaceutics and Industrial Pharmacy department from
20/3/2002.

22- Honor of the Faculty of Pharmacy Council from 14/10/2003.

23- Head of the First year control in Faculty of Pharmacy, Al-Azhar University,
academic year 2002/2003.

24- Head of the Second year control in Faculty of Pharmacy, Al-Azhar University,
academic year 2003/2004.

25- Member of the Fourth year control in Faculty of Pharmacy, Al-Azhar
University, academic year 2004/2005.

26- Member of the Fourth year control in Faculty of Pharmacy, Al-Azhar
University, academic year 2005/2006.

27- Member of the Fourth year control in Faculty of Pharmacy, Al-Azhar
PDF created with pdfFactory Pro trial versi Experience
1- Teaching practical pharmaceutics in the Faculty of Pharmacy, Cairo University,
from 1974 to 1980.

2- Assistant lecturer in Pharmaceutics, Faculty of Pharmacy, Cairo University,
1980.

3- Teaching courses in Pharmaceutics in Faculty of Pharmacy, Cairo University,
from 1980 to 1982.

4- I went to England, U K, in a post-graduated mission leading to Ph.D. in behalf
of Al-Azhar University in 1982.

5- I got the degree of Ph.D. in Pharmaceutics from the University of Wales,
Institute of Science and Technology (UWIST) in July 1986.

6- Lecturer in Pharmaceutics, Faculty of Pharmacy, Al-Azhar University, 1986.

7- Teaching pharmaceutical courses for the second and third year students in the
Faculty of Pharmacy, Al-Azhar University from 1986 to 1993.

8- Assistant professor in Pharmaceutics, Faculty of Pharmacy, Al-Azhar University,
1993.

9- Teaching pharmaceutical courses for the second and forth year students in the
Faculty of Pharmacy, Al-Azhar University from 1993 to 1998.

10- Teaching pharmaceutical courses for the second and forth year students in
the Faculty of Pharmacy for GIRLS, Al-Azhar University from 1996 to 1998.

11- Professor in Pharmaceutics, Faculty of Pharmacy, Al-Azhar University, 1998

12- Teaching pharmaceutical courses for the second year (Physical Pharmacy)
and forth year (Biopharmaceutics and Pharmacokinetics) students in the Faculty of Pharmacy, Al-Azhar University from 1998 until now.
13- Teaching pharmaceutical courses for the second year (Physical Pharmacy)
and forth year (Biopharmaceutics and Pharmacokinetics) students in the Faculty of
Pharmacy for GIRLS, Al-Azhar University from 1998 until now.

14- Teaching special courses for M.Sc. and Ph.D. post-graduated students in
Pharmaceutics Dept., Faculty of Pharmacy, Al-Azhar University especially courses
in Physical Pharmacy and courses in Preformulation of Drugs from 1993 until now.

15- Teaching pharmaceutical courses for the fifth level (pharmacokinetics, course
504) and fourth level (sterile products and radio-pharmacy, course 403) students
in Misr University for Science and Technology (MUST), 6Th of October , 2002.
PDF created with pdfFactory Pro trial versi 16- Teaching pharmaceutical courses for the fifth level (pharmacokinetics, course
504) Students (summer course) in Misr University for Science and Technology
(MUST), 6Th of October , Jully, 2002.

17- Teaching pharmaceutical courses for the fourth year (Design and formulation
of dosage forms, course 416) students in Misr International University (MIU),
2002/2003.

18- Teaching pharmaceutical courses for the fourth year (kinetics and drug
stability, course 421) students in Misr International University (MIU), 2003/2004

19- Teaching pharmaceutical courses for the fifth level (Drug formulation and
dosage form design, course 506) students (summer course) in Misr University for
Science and Technology (MUST), 6Th of October , 2004.

20- Teaching pharmaceutical courses for the fifth level (Drug formulation and
dosage form design, course 506) students in Misr University for Science and
Technology (MUST), 6Th of October, 2004/2005.

21- Teaching pharmaceutical courses for the first year, first semester (Pharmacy
orientation and history of pharmacy, course PHT 101) students in Faculty of
Pharmacy and Pharmaceutical Industry, Sinai University, 2006/2007.

22- Teaching pharmaceutical courses for the first year, second semester (Physical
Pharmacy, course PHT 202) students in Faculty of Pharmacy and Pharmaceutical
Industry, Sinai University, 2006/2007.
PDF created with pdfFactory Pro trial versi Scientific Thesis Supervision
M. Sc. Thesis supervisor
A) Theses have gotten the degree 1- Alaa El-Din Bakry Yassin B) Theses sill in progress 1- Tamer Ahmed Aly Refaae 2- Saleh Seleem Ahmed Seleem 3- Wael Mohamed Kamal Adbel-Reheem Farghal 4- Mohamed Abdel-Mena’m Aly Raslan 5- Hamdy Mohamed Mahmoud Dawaba 7- Khalid Hussin Zaki 8- Sherif Shokry Abdel-Haleem Hafez 9- Maha Khalifa Ahmed Khalifa 10- Abdel-Fatah Ibrahim Abdel-Fatah 11- Mohamed Abdal ah Mohamed Atia 12- Rashad Mostafa Mohamed Kaaoud 13- Abdel-Sabour Ahmed Ali 14- Yasmin Mohamed Hassan Mahmoud 15- Nehal Samir Maree Sayed Naser PDF created with pdfFactory Pro trial versi Ph. D. Thesis supervisor
A) Theses have gotten the degree
5- Khalid Mohamed Mohamed Mohamed El-Say 10- Sherif Khalifa Abu-Elyazed El-Sherif 11- Abdel Aziz El-Sayed Abdel Aziz Abd rabou 1- Hosam Abdel-Hameed Mahmoud Hefesha 2- Khalid Shalaby Mohamed Ahmed 3- Ghada Ihab Yassin Yousef 4- Shaban Khalaf Abdel Hameed Osman 5- Sayed Hasan Mohamed Odaa 6- Saleh Abdel Rasool Ibrahim Abdel Hameed 7- Mohamed Mahmoud Mohamed Mohamed Badran 8- Reham Ibrahim Mohamed Amer 9- Tarek Abdel Naby Ahmed Abdel Naby 10- Hany Mahmoud Ibrahim Mahmoud 11- Hatem Roshdy Al-Sayed Ismael PDF created with pdfFactory Pro trial versi M. Sc. Thesis Discussion

1- Manal Kamal Darwish
14- Ahmed Abdel-Fattah Hafez Abdel-Latif
Ph. D. Thesis Discussion
PDF created with pdfFactory Pro trial versi Conference Attendance
1- British Pharmaceutical Conference, London, 13-17 Sept., 1983, J. Pharm.
Pharmacol., 35, 56p, 1983.
2- The XXI Conference of Pharmaceutical Sciences, Cairo, Egypt, 24 - 27 Feb.,
1990, two scientific papers.
3- PAN-PACIFIC VI Conference, " Focus on Therapeutic Innovation", Honolulu,
Hawaii, USA, 19-23 May, 1991.
4- Second Anglo-Egyptian Conference of Pharmaceutical Sciences, Alexandria,
Egypt, 9-12 Nov., 1991.
5- The AAPS Annual Meeting, Washington DC, USA, 17-19 Nov., 1991.
6- The Egyptian Society of Clinical Chemistry, 37th Scientific Congress, 21-23 Dec.,
1992.
7- The AAPS Annual Meeting, Florida, USA, 14-18 Nov., 1993.
8- Al-Azhar First International Conference on Recent Advances in Pharmaceutical
Technology and Biological Sciences, 19-21 Dec., 1995, Cairo, Egypt, three
scientific papers.
9- The AAPS Annual Meeting and Exposition, Indianapolis IN, USA, Oct. 29 – Nov.
2, 2000, p. 135 of 273.
10- Al-Azhar Second International Conference for Pharmaceutical and Biological
Sciences, 19-21 Dec., 2001, Cairo, Egypt, nine scientific papers.
11- The 63th international congress of FIP (Federal international conference for
pharmacists association), Sydney, Australia, 6-8 Sept., 2003, No 29, Code: BB-P-
001.
12- The AAPS Annual Meeting and Exposition, Salt Lake City, Utah, USA, 26 –30
Oct., 2003, ID: AM-03-00311.
13- Al-Azhar Third International Conference for Pharmaceutical and Biological
Sciences, 16-18 Dec., 2003, Cairo, Egypt, twelve scientific papers.
14- The AAPS Annual Meeting and Exposition, Baltimore, MD, USA, Nov. 7-11,
2004.
15- IXXX Conference of Pharmaceutical Sciences and VIII Conference of the
Colleges of Pharmacy in the Arab World, 21-23 December 2004, Air defense
house, Nasr City, Cairo, Egypt.
16- The 8th International Conference and Exhibition on Drug Discovery, 9-12 May
2005, Basel, Switzerland.
17- Al-Azhar 4th International Conference for Pharmaceutical and Biological
Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt. 18- The 7th International Saudi Pharmaceutical Conference, March 19th to 21st ,
2007, Riyadh, Saudi Arabia, Poster No. PR-P-23.
PDF created with pdfFactory Pro trial versi Published Papers
1) The Influence of Ions on the Micel ization of Phenothiazines. Ahmed, A.M.S.
and Kellaway, I.W., J. Pharm. Pharmacol., 35, 56p, 1983.
2) The Thermodynamics of Partitioning of Phenothiazines Between Phosphate
Buffer and the Lipid Phases of Cyclohexane, n-Octanol and DPPC Liposomes.
Ahmed. A.M.S., Farah, F.H. and Kellaway, I.W., Pharm. Res., 3, 119-124, 1985.
3) Antimicrobial Activity of Liometacin. Helal, A-S. A-S and Ahmed, A.M.S.,
Proceeding of the XXI Conference of Pharmaceutical Sciences, 461-470, 1990.
4) Enhanced Dissolution of Griseofulvin. Ahmed, A.M.S., Ibrahim, E.A. and Byomi,
M.A., The XXI Conference of Pharmaceutical Sciences, A5, 1990.
5) Comparative Bioavailability of Five Commercial Oral Suspensions of Ampicillin
Utilizing Urinary Excretion Data. Byomi, M.A., Ahmed, A.M.S., Ibrahim, E.A. and
Fetouh, M.I., J. Bio. Med. Sci. Ther., 7, 148-159, 1991.
6) Indomethacin Direct-Compression Excipients; Preformulation Stability
Screening Using Differential Scanning Caloremetry. El-Shattawy, H.H., Kassem,
A.A., Ahmed, A.M.S. and Yassin, A.B., Pan Pacific VI Conference, Honolulu,
Hawaii, USA, p10, 162, 1991.
7) Interaction of Chlorpromazine Hydrochloride with Cholesterol Inhibiting
Liposome-Formation. Fetouh, M.A., Ahmed, A.M.S., Omar, S.M. and El-Ridy, M.S.,
Alex. J. Pharm. Sci., 6, 89-91, 1992.
8) The Thermodynamics of Phenothiazine Partitioning between Phosphate Buffer
and DMPC Liposomes as Studied by Ultra-filtrationTechnique. Ahmed, A.M.S., Az.
J. Pharm. Sci., 10, 1-16, 1992.
9) Bioavailability of Directly-Compressed Indomethacin, Indomethacin Sodium and
Indomethacin Meglumine Tablets. El-Shattawy, H.H., Kassem, A.A., Omar, S.M.,
Ahmed, A.M.S. and Yassin, A.B., Drug Devel. Ind. Pharm., 20(3), 367-373, 1994.
10) Preparation and Evaluation of Directly-Compressed Indomethacin,
Indomethacin Sodium and Indomethacin Meglumine Tablets. El-Shattawy, H.H.,
Kassem, A.A., Omar, S.M., Ahmed, A.M.S. and Yassin, A.B., Drug Devel. Ind. Pharm., 20(5), 901-909, 1994.
11) Formulation of Nitrofurantoin Tablets Fulfilling the Pharmacopoeial
Specifications. Hosny, E.A. and Ahmed, A.M.S., Drug Devel. Ind. Pharm., 20(9),
1631-1638, 1994.
12) Liposomal Indomethacin; Preparation and In-Vitro Release. Ahmed, A.M.S., J.
Biomed. Sci. Ther., 10(8), 10-23, 1994.
13) Hypoglycemic Effect of Orally Administered Liposome-Entrapped Insulin in
Streptozotocinized Rabbits. El-Shattawy, H.H., Abu-Zaid, S.S., Ahmed, A.M.S., Hosny, E.A. and Attia, F.F.M., Arab. J. Lab. Med., 22(1), 175-185, 1996.
14) Preparation and Evaluation of Nitrofurantoin Solid Dispersion-Containing
Powders, Directly-Compressed Tablets and Capsules. El-Shattawy, H.H., Kassem,
A.A., Ahmed, A.M.S. and El-Gendy, A.M., Az. J. Pharm. Sci., 17, 116-128, 1996.
15) Comparative Bioavailability of Nitrofurantoin Solid Dispersion-Containing
Tablets and Capsules. El-Shattawy, H.H., Kassem, A.A., Ahmed, A.M.S. and El-
Gendy, A.M., Az. J. Pharm. Sci., 17, 129-137, 1996.
16) Oil in Water Microemulsion of Verapamil as a Model for Transdermal drug
Delivery System. Ahmed, A.M.S., Az. J. Pharm. Sci., 19, 9-21, 1997.
17) Accelerated Stability Testing and Shelf-Storage Stability of Nitrofurantoin Solid
Dispersion-Containing Tablet and Capsule Formulations. El-Shattawy, H.H.,
Kassem, A.A., Ahmed, A.M.S. and El-Gendy, A.M., Egypt. J. Biotechnol., 2, 41-49,
PDF created with pdfFactory Pro trial versi 18) Preformulation Studies on Controlling the Release of Verapamil Hydrochloride
from Trans-dermal Drug Delivery System (TDDS), part I- In-vitro Release from
Ointment and Gel Bases. El-Shattawy, H.H., Kassem. A.A., Ahmed, A.M.S. and
Mohamed, B.S., Egypt. J. Biotechnol, 3, 11-25, 1998.
19) Preformulation Studies on Controlling the Release of Verapamil Hydrochloride
from Trans-dermal Drug Delivery System (TDDS), part II- In-vitro release from Eudragit Films, El-Shattawy, H.H., Kassem, A.A., Ahmed, A.M.S. and Mohamed, B.S., Egypt. J. Biotechnol, 3, 26-44, 1998. 20) Preformulation Studies on Controlling the Release of Verapamil Hydrochloride
from Trans-dermal Drug Delivery System (TDDS), part III- In-vitro Permeation via
Natural and Synthetic Membranes, El-Shattawy, H.H., Kassem, A.A., Ahmed,
A.M.S. and Mohamed, B.S., Arab J. Lab. Med., 24(3), 311-334, 1998.
21) Preformulation Studies on Controlling the release of Verapamil Hydrochloride
from Trans-dermal Drug Delivery System (TDDS), part IV- Pharmacokinetics and
Bioavailability Following Intravenous, Oral and Transdermal Administration in
Rabbits, El-Shattawy, H.H., Kassem, A.A., Ahmed, A.M.S. and Mohamed, B.S.,
Arab J. Lab. Med., 24(3), 335-358, 1998.
22) HPLC Evaluation and Bioavailability of Nicardipine Hydrochloride Capsules and
Tablets, Ahmed, A.M.S., Moustafa, A.M., El-Abassawy, N.M., Ramadan, A.A. and
Fetouh, M.I., Az. J. Pharm. Sci., 116-129, 2000.
23) Formulation, In-vitro Evaluation and Kinetic Study of Nicardipine
Hydrochloride Powders, Capsules, and Tablets Prepared as Solid Dispersion Using
Ethyl Cellulose Polymer, A.M.S. Ahmed, A.A. Ramadan and M.I. Fetouh, Al-Azhar
Second International Conference for Pharmaceutical and Biological Sciences, 19-21
Dec., 2001, Cairo, Egypt, p 88.
24) Accelerated Stability Testing and Shelf-Storage Stability of Nicardipine
Hydrochloride Capsules, and Tablets Prepared as Solid Dispersion Using Ethyl Cellulose Polymer, A.M.S. Ahmed, A.A. Ramadan and M.I. Fetouh, Al-Azhar Second International Conference for Pharmaceutical and Biological Sciences, 19-21 Dec., 2001, Cairo, Egypt, p 92.
25) Formulation, In-vitro Evaluation and Kinetic Study of Verapamil Hydrochloride
from Different Suppository Bases, Ahmed, A.M.S., El-Adawy, S.A.I. and Kassem, A.A., Al-Azhar Second International Conference for Pharmaceutical and Biological Sciences, 19-21 Dec., 2001, Cairo, Egypt, p 93. 26) Accelerated Stability Testing and Shelf Storage Stability of Verapamil HCl
Suppositories, Ahmed, A.M.S., El-Adawy, S.A.I. and Kassem, A.A., Al-Azhar Second
International Conference for Pharmaceutical and Biological Sciences, 19-21 Dec., 2001, Cairo, Egypt, p 91.
27) Pharmacokinetic and Bioavailability of Verapamil HCl Fol owing Its
Intravenous, Oral and Rectal Administration in Rabbits, Ahmed, A.M.S., El-Adawy, S.A.I. and Kassem, A.A., Al-Azhar Second International Conference for Pharmaceutical and Biological Sciences, 19-21 Dec., 2001, Cairo, Egypt, p 92. 28) Formulation and Micromeritic Evaluation of Diclofenac potassium Coated
Granules Prepared by Top-spray Fluid-bed, Ahmed, A.M.S., Khattab, I.S., Zaki,
A.A. and Fetouh, M.I., Az J. Pharm. Sci., 28, 350-359, 2001.
29) Stability of Diclofenac potassium Capsules and Tablets Prepared by Top-spray
Fluid-bed, Ahmed, A.M.S., Khattab, I.S., Zaki, A.A. and Fetouh, M.I., Az J. Pharm.
Sci., 27, 350-365, 2001.
PDF created with pdfFactory Pro trial versi 30) Formulation and In-vitro Evaluation of Diclofenac potassium Capsules and
Tablets Prepared by Top-spray Fluid-bed, Ahmed, A.M.S., Khattab, I.S., Zaki, A.A.
and Fetouh, M.I., Egypt. J. Biotechnol., 10, 379-404, 2001.
31) Formulation, In-vitro Evaluation and Microbiological Studies of Fluconazole
from Different Pharmaceutical Topical Preparations, Ahmed, A.M.S., Mowafy, H.A.
and Fetouh, M.I., Al-Azhar Second International Conference for Pharmaceutical
and Biological Sciences, 19-21 Dec., 2001, Cairo, Egypt, p 85.
32) Formulation, In-vitro Release and Rheological Studies of Different Topical
Pharmaceutical Preparations Containing 2% Fluconazole, Ahmed, A.M.S., Mowafy,
H.A. and Fetouh, M.I., Al-Azhar Second International Conference for
Pharmaceutical and Biological Sciences, 19-21 Dec., 2001, Cairo, Egypt, p 89.
33) Effect of polymer on the formulation, micromeritic properties, in-vitro
evaluation and stability testing of Salbutamol sulfate microcapsules prepared by
the emulsion solvent- evaporation technique, Ahmed, A.M.S., El-Say, K.M. and
Fetouh, M.I. Az J. Pharm. Sci., 28, 300-318, 2001.
34) Effect of polymer on the formulation, micromeritic properties, in-vitro
evaluation and stability testing on Ibuprofen microcapsules prepared by the
emulsion solvent- evaporation technique, Ahmed, A.M.S., El-Say, K.M. and Fetouh,
M.I., Az J. Pharm. Sci., 28, 267-284, 2001.
35) The influence of the independent variables on the micromeritic properties and
the in-vitro release of Terbutaline sulfate capsules, Ahmed, A.M.S., Khattab, I.S., Lila, A.S., and Fetouh, M.I., Al-Azhar Third International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo, Egypt, (Poster 26) p 62.
36) Characterization of control ed release Terbutaline sulfate capsules, Ahmed,
A.M.S., Khattab, I.S., Lila, A.S., and Fetouh, M.I., Al-Azhar Third International
Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo, Egypt, (Poster 27) p 63. 37) Formulation, in-vitro evaluation, kinetic study and stability testing of
Terbutaline sulfate capsules, Ahmed, A.M.S., Khattab, I.S., Lila, A.S., and Fetouh, M.I., Al-Azhar Third International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo, Egypt, (Poster 28) p 64.
38) Stability of Indomethacin tablets, Ahmed, A.M.S., Ramadan, A.A., and Fetouh,
M.I., Al-Azhar Third International Conference for Pharmaceutical and Biological
Sciences, 16-18 Dec., 2003, Cairo, Egypt, (Poster 29) p 65.
39) Formulation, in-vitro evaluation and kinetic studies of Indomethacin tablets,
Ahmed, Ahmed, A.M.S., Ramadan, A.A., and Fetouh, M.I., Al-Azhar Third International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo, Egypt, (Poster 30) p 66. 40) Pre-formulation studies of Indomethacin with solid dispersion polymers and
tablet excipient, Ahmed, A.M.S., Ramadan, A.A., and Fetouh, M.I., Al-Azhar Third
International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec.,
2003, Cairo, Egypt, (Poster 31) p 67.
41) Accelerated stability and shelf-storage stability testing of Indomethacin
tablets, Ahmed, A.M.S., Abd-allah, F.I., and Fetouh, M.I., Al-Azhar Third
International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec.,
2003, Cairo, Egypt, (Poster 32) p 68.
42) Formulation, in-vitro evaluation and kinetic parameters of Indomethacin
tablets, Ahmed, A.M.S., Abd-allah, F.I., and Fetouh, M.I., Al-Azhar Third
PDF created with pdfFactory Pro trial versi International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo, Egypt, (Poster 33) p 69. 43) Bioavailability and pharmacokinetic parameters of Indomethacin tablets,
Ahmed, A.M.S., Abd-allah, F.I., and Fetouh, M.I., Al-Azhar Third International
Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo,
Egypt, (Poster 34) p 70.
44) Ex-vivo study of different Mebeverine Hydrochloride suppositories on isolated
guinea pig colon, Ahmed, A.M.S. and El-Sherif, S.K.A., Al-Azhar Third International
Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo,
Egypt, (Poster 35) p 71.
45) Accelerated stability and shelf-storage stability testing of Mebeverine HCl
suppositories, Ahmed, A.M.S. and El-Sherif, S.K.A., Al-Azhar Third International
Conference for Pharmaceutical and Biological Sciences, 16-18 Dec., 2003, Cairo,
Egypt, (Poster 36) p 72.
46) Preformulation, quality control tests, in-vitro release and kinetic studies of
Mebeverine HCl suppositories, Ahmed, A.M.S. and El-Sherif, S.K.A., Al-Azhar Third
International Conference for Pharmaceutical and Biological Sciences, 16-18 Dec.,
2003, Cairo, Egypt, (Poster 37) p 73.
47) The application of a pharmacokinetic computer program and High
Performance Liquid Chromatography (HPLC) for studying the pharmacokinetics
and bioavailability of Verapamil HCl following their Intravenous, oral and rectal administration to rabbits, Ahmed, A.M.S., and Al-Abasawy, N.M., Az. J. Pharm. Sci., 31, 227-239 (2003). 48) Influence of Meloxicam gel on the lipid structure of excised human stratum
corneum using DSC, Fetouh, M.I., Ahmed, A.M.S., Mul er-Goymann, C.C. and
Mowafy, H.A., APPS meeting, Nov 7-11, 2004, Baltimore, MD, USA.
49) Formulation and characterization of Nicardipine HCl microspheres, Ahmed,
A.M.S., Marzouk, M.A., and Yassin, G.E., IXXX Conference of Pharmaceutical
Sciences and VIII Conference of the Col eges of Pharmacy in the Arab World, 21- 23 December 2004, Air defense house, Nasr City, Cairo, Egypt, p 95.
50) Bioavailability assessment of salbutamol sulfate suppositories in human
volunteers, Taha, E.I., Zaghloul, A.A., Ahmed, A.M.S., Al-Saidan, S.M., Kassem,
A.A., and Khan, M.A., Int. J. Pharm., 279 (1-2), 3-7 (2004).
51) Preparation and in-vitro characterization of self-nanoemulsified drug delivery
system (SNEDDS) of al -trans-retinol acetate, Taha, E.I., Al-Saidan, S.M., Ahmed, A.M.S., and Khan, M.A., Int. J. Pharm., 285 (1-2), 109-119 (2004). 52) Bioavailability and pharmacokinetics of Nicardipine HCl microspheres, Ahmed,
A.M.S., Marzouk, M.A., and Yassin, G.E., Egypt. J. Biomed. Sci., 16, 168-179, 2004. 53) Response surface methodology of self-nanoemulsified drug delivery system
(SNEDDS) of all-trans-retinol acetate, Taha, E.I., Ahmed, A.M.S., Kassem, A.A.,
and Khan, M.A., Pharm. Dev. Technol., 2005.
54) Influence of Meloxicam gel on the lipid structure of excised human stratum
corneum using DSC, Fetouh, M.I., Ahmed, A.M.S., Mul er-Goymann, C.C. and
Mowafy, H.A., The 8th International Conference and Exhibition on Drug Discovery,
9-12 May 2005, Basel, Switzerland, poster No. 125.
55) Accelerated stability testing for some topical formulations of meloxicam via
rheological behaviour testing depending on storage, Mowafy, H.A., Ahmed, A.M.S.,
Fetouh, M.I., and Mul er-Goymann, C.C., Al-Azhar 4th International Conference for
PDF created with pdfFactory Pro trial versi Pharmaceutical and Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 25. 56) Preformulation, quality control tests, in-vitro release and kinetic studies of
ranitidine HCl suppositories, Kassem, A.A., Ahmed, A.M.S., and Shalaby, K., Al-
Azhar 4th International Conference for Pharmaceutical and Biological Sciences,
February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 17.
57) Bioavailability and pharmacokinetic parameters of ranitidine HCl suppositories
using HPLC technique, Shalaby, K., Kassem, A.A., Ahmed, A.M.S., and El-Abasawy,
N., Al-Azhar 4th International Conference for Pharmaceutical and Biological
Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt,
Poster No. 19.
58) Accelerated stability and shelf storage stability testing of ranitidine HCl
suppositories, Ahmed, A.M.S., Kassem, A.A., and Shalaby, K., Al-Azhar 4th
International Conference for Pharmaceutical and Biological Sciences, February 13-
15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 18.
59) Preliminary investigation and in-vitro release of diclofenac sodium
microspheres, Hefisha, H.A., Ahmed, A.M.S., and El-Abd, S.A., Al-Azhar 4th
International Conference for Pharmaceutical and Biological Sciences, February 13-
15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 15.
60) Statistical correlation and factorial characterization of diclofenac sodium
microspheres., Ahmed, A.M.S., Hefisha, H.A., and El-Abd, S.A., Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 16. 61) Statistical correlation and factorial characterization of controlled release
diclofenac sodium microspheres and capsules, Ahmed, A.M.S., Abdel-Aziz, A.E.,
and Kassem, A.A., Al-Azhar 4th International Conference for Pharmaceutical and
Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 13. 62) Formulation, in-vitro evaluation and kinetic parameters of diclofenac sodium
capsules, Ahmed, A.M.S., Abdel-Aziz, A.E., and Kassem, A.A., Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, February 13- 15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 12.
63) Formulation, quality control tests, in-vitro evaluation and kinetic parameters
of diclofenac sodium tablets, Ahmed, A.M.S., Abdel-Aziz, A.E., and Kassem, A.A.,
Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 11. 64) Preformulation studies to increase the aqueous solubility and dissolution of
ketoconazole, Ahmed, A.M.S., Badran, M.M.M., and El-Abd, S.A., Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, February 13- 15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 20.
65) Formulation, in-vitro release, rheological parameters and microbiological
studies of ketoconazole from different pharmaceutical topical preparations,
Ahmed, A.M.S., Badran, M.M.M., and El-Abd, S.A., Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 21. 66) Formulation and evaluation of Rofecoxib liquisolid tablets, Fetouh, M.I.,
Ahmed, A.M.S., and El-Say, K.M., Al-Azhar 4th International Conference for
Pharmaceutical and Biological Sciences, February 13-15, 2006, Air Defense House,
Nasr City, Cairo, Egypt, Poster No. 3.
PDF created with pdfFactory Pro trial versi 67) Optimization of Rofecoxib liquisolid tablets using Box-Behnken design and
desirability function, El-Say, K.M., Ahmed, A.M.S., and Fetouh, M.I., Al-Azhar 4th
International Conference for Pharmaceutical and Biological Sciences, February 13-
15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 4.
68) Optimization of piroxicam niosome formulae using central composite design,
Lila, A.S., Ahmed, A.M.S., and Fetouh, M.I., Al-Azhar 4th International Conference for Pharmaceutical and Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 2. 69) Optimization of self-nanoemulsified Tenoxicam capsule using response
surface methodology, Ibrahim, F.A., Ahmed, A.M.S., and Fetouh, M.I., Al-Azhar 4th
International Conference for Pharmaceutical and Biological Sciences, February 13-
15, 2006, Air Defense House, Nasr City, Cairo, Egypt, Poster No. 5.
70) Influence of meloxicam gel on the lipid structure of excised human stratum
corneum using DSC, Muller-Goymann, C.C., Mowafy, H.A., Ahmed, A.M.S., and
Fetouh, M.I., Al-Azhar 4th International Conference for Pharmaceutical and
Biological Sciences, February 13-15, 2006, Air Defense House, Nasr City, Cairo,
Egypt, Poster No. 14.
71) Study on the possible modulation of the anti-inflammatory and analgesic
effects of liquisolid tablets of Rofecoxib in rats, Abo-Salem, O.M., El-Say, K.M.,
Ahmed, A.M.S., and Fetouh, M.I., Egypt. J. Biomed. Sci., 21, 140-152, 2006.
72) Formulation and evaluation of Rofecoxib liquisolid tablets, El-Say, K.M.,
Ahmed, A.M.S., and Fetouh, M.I., The 7th International Saudi Pharmaceutical Conference, March 19th – 21st . 2007, Poster No. PR – P – 23. PDF created with pdfFactory Pro trial versi

Source: http://www.media.su.edu.eg/members/media_files/Full%20CV_%20Dr_Ahmed%20Samy.pdf